Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
J Neurol
; 265(11): 2540-2547, 2018 Nov.
Article
in En
| MEDLINE
| ID: mdl-30167879
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-8
/
Interleukin-6
/
Multiple Sclerosis, Relapsing-Remitting
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Neurol
Year:
2018
Document type:
Article
Affiliation country:
Italy
Country of publication:
Germany